2[1]Brandes AA,Ermani M,Basso U,et al.Temozolomide as a second-line systemic regimen in recurrent high-grade glioma:a phase II study[J].Ann Oncol,2001,12:255.
3[2]Kortmann RD,Jeremic B,Weller M,et al.Radiochemotherapy of malignant glioma in adults.Clinical experiences[J].Strahlenther Onkol,2003,179:219.
4[3]Banna GL,Bettio D,Scorsetti M,et al.Administration of temozolomide during and after radiotherapy for newly diagnosed high-grade gliomas excluding glioblastoma multiforme[J].J Neurooncol,2007,81:323.
5[4]Stevenson PH.Height-Weight-Surface formula for the estimation of surface area in Chinese subjects[J].Chin J Physiol,1937,12:327.
6[6]Mason WP,Cairncross JG.Drug Insight:temozolomide as a treatment for malignant glioma--impact of a recent trial[J].Nat Clin Pract Neurol,2005,1:88.
7[7]De Sanctis V,Mazzarella G,Osti MF,et al.Radiotherapy and sequential temozolomide compared with radiotherapy with concomitant and sequential temozolomide in the treatment of newly diagnosed glioblastoma multiforme[J].Anticancer Drugs,2006,17:969.
8[8]van Rijn J,Heimans JJ,van den Berg J,et al.Survival of human glioma cells t reated with various combination of temozolomide and x-rays[J].Int J Radiat Oncol Biol Phys,2000,47:779.
9[9]Kocher M,Kunze S,Eich HT,et al.Efficacy and Toxicity of Postoperative Temozolomide Radiochemotherapy in Malignant Glioma[J].Strahlenther Onkol,2005,181:157.
10[1]Brandes A,Ernani M,Basso U,et al.Temozolomide as a secondline systemic regimen in recurrent highgrade glioma:a phase Ⅱ study[J].Ann Oncol,2001,12(2):255～257.
